Celexa,
Citalopram,
Citalopram Hydrobromide,
Cytalopram,
Escitalopram,
Escitalopram Oxalate,
Lexapro,
Lu-10-171,
Lu10171,
Seropram,
Escitalopram oxalate,
219861-08-2,
Cipralex,
Lexapro,
(S)-Citalopram Oxalate,
Escitalopram (oxalate),
Citalopram Oxalate,
(S)-(+)Citalopram oxalate,
UNII-5U85DBW7LO,
5U85DBW7LO,
Esertia,
(S)-(+)-Citalopram Oxalate,
(S)-1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate,
NCGC00095903-01,
Lu 26-054-0,
DSSTox_CID_26003,
DSSTox_RID_81282,
DSSTox_GSID_46003,
escitalopram oxalate inn,
C22H23FN2O5,
128196-01-0,
S-(+)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate,
5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-, ethanedioate (1:1),
S-(+)-5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, oxalate,
CAS-219861-08-2,
Lu-26-054-0,
Gaudium,
Entact,
MFCD06407826,
escitalopram-oxalate,
(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile; oxalic acid,
(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Oxalate,
Lexapro (TN),
AC1L3TGZ,
Escitalopram oxalate [USAN],
SCHEMBL35123,
cc-372,
MLS001401408,
SPECTRUM1505216,
(+)-(S)-Citalopram oxalate,
MLD-55,
CHEMBL1200322,
DTXSID1046003,
AOB4715,
Escitalopram oxalate (JAN/USAN),
Escitalopram oxalate [USAN:USP],
KTGRHKOEFSJQNS-BDQAORGHSA-N,
HMS2051D11,
HMS2231M16,
HMS3370I17,
HMS3393D11,
HMS3713D16,
Pharmakon1600-01505216,
(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid,
BCP05686,
Tox21_111535,
BG0433,
CCG-39559,
HY-14258A,
NSC758934,
AKOS016340275,
Tox21_111535_1,
AC-6770,
AN-9671,
CS-2054,
KS-1263,
NC00194,
NSC-758934,
SB17454,
NCGC00178555-02,
AK138215,
AN-13009,
CPD000469191,
SAM001246668,
SMR000469191,
AB0012102,
AX8019428,
LS-183519,
LU-260540,
TL8001823,
E0958,
FT-0650410,
ST24046691,
D02567,
Escitalopram oxalate, >=98% (HPLC), powder,
J90016,
Escitalopram pound Escitalopram Oxalate pound(c),
861E082,
SR-01000763053,
SR-01000763053-3,
UNII-B5RDX2419X component KTGRHKOEFSJQNS-BDQAORGHSA-N,
Escitalopram oxalate, EuropePharmacopoeia (EP) Reference Standard,
Escitalopram oxalate, United States Pharmacopeia (USP) Reference Standard,
Escitalopram for system suitability, EuropePharmacopoeia (EP) Reference Standard,
Escitalopram Oxalate, Pharmaceutical Secondary Standard; Certified Reference Material,
(+)-(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate,
(1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Ethanedioate,
(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile; oxalic acid,
5-Isobenzofurancarbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-,ethanedioate (1:1),
S-(+)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile oxalate,
Escitalopram,
Seroplex,
(R)-Citalopram Oxalate,
S-(+)-Citalopram oxalate,
CID146571,
B2238,
219861-53-7,